52: A Single Dose of Gemtuzumab-Ozogamicin (GO) in Consolidation Prior to Autologous Transplant for Younger Patients with Newly Diagnosed Acute Myeloid (AML) is Safe But Has No Effect on Disease Free Survival: Interim Results of Eastern Cooperative Oncology Group Study (E1900)